• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of exudative age-related macular degeneration: many factors to consider.

作者信息

Olsen Timothy W

机构信息

Department of Ophthalmology, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Am J Ophthalmol. 2007 Aug;144(2):281-3. doi: 10.1016/j.ajo.2007.05.005.

DOI:10.1016/j.ajo.2007.05.005
PMID:17659955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2040182/
Abstract
摘要

相似文献

1
Treatment of exudative age-related macular degeneration: many factors to consider.渗出性年龄相关性黄斑变性的治疗：诸多需考虑的因素。
Am J Ophthalmol. 2007 Aug;144(2):281-3. doi: 10.1016/j.ajo.2007.05.005.
2
Ranibizumab vs. pegaptanib: a cost-effectiveness study?雷珠单抗与培加他尼：一项成本效益研究？
Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1675; author reply 1677. doi: 10.1007/s00417-010-1390-1. Epub 2010 Apr 28.
3
[A new drug for macular degeneration. A breakthrough accomplished (interview by Waldtraud Paukstadt)].[一种治疗黄斑变性的新药。一项已取得的突破（瓦尔特拉德·保克施塔特采访）]
MMW Fortschr Med. 2007 Jan 18;149(3):13-4.
4
[Treatment of neovascular age-related macular degeneration with bevacizumab].[贝伐单抗治疗新生血管性年龄相关性黄斑变性]
Farm Hosp. 2006 Nov-Dec;30(6):387-8. doi: 10.1016/s1130-6343(06)74013-2.
5
Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors.雷珠单抗用于曾接受其他血管内皮生长因子抑制剂治疗的眼中的渗出性年龄相关性黄斑变性。
Ophthalmic Surg Lasers Imaging. 2010 Mar-Apr;41(2):182-9. doi: 10.3928/15428877-20100303-05.
6
Aqueous vascular endothelial growth factor after intravitreal injection of pegaptanib or ranibizumab in patients with age-related macular degeneration.玻璃体内注射培加他滨或雷珠单抗后年龄相关性黄斑变性患者的血管内皮生长因子。
Retina. 2010 Jul-Aug;30(7):1034-8. doi: 10.1097/IAE.0b013e3181ce74c8.
7
A cost-effectiveness analysis of three treatments for age-related macular degeneration.三种治疗年龄相关性黄斑变性方法的成本效果分析。
Retina. 2010 Feb;30(2):212-21. doi: 10.1097/IAE.0b013e3181babd8e.
8
Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration.雷珠单抗与聚乙二醇化阿柏西普治疗新生血管性年龄相关性黄斑变性的成本效果比较。
Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):467-76. doi: 10.1007/s00417-009-1156-9. Epub 2009 Aug 11.
9
Anti-VEGF therapeutic approaches for diabetic macular edema.用于治疗糖尿病性黄斑水肿的抗血管内皮生长因子治疗方法。
Int Ophthalmol Clin. 2009 Spring;49(2):109-19. doi: 10.1097/IIO.0b013e31819fd8b5.
10
[New drug treatment for age-related macular degeneration].[年龄相关性黄斑变性的新药治疗]
Laeknabladid. 2007 Apr;93(4):299-301.

引用本文的文献

1
The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration.年龄相关性眼病研究2：微量营养素治疗黄斑变性
Adv Nutr. 2017 Jan 17;8(1):40-53. doi: 10.3945/an.116.013177. Print 2017 Jan.
2
Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).对于先前接受雷珠单抗或贝伐单抗治疗渗出性年龄相关性黄斑变性的患者，转换为阿柏西普治疗6个月后的光学相干断层扫描和视力结果（美国眼科学会论文）
Trans Am Ophthalmol Soc. 2014 Jul;112:160-98.
3
Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation.葡萄膜炎、年龄相关性黄斑变性治疗试验（CATT）的比较，以及眼内生物制剂治疗眼部炎症。
Am J Ophthalmol. 2012 Sep;154(3):429-435.e2. doi: 10.1016/j.ajo.2012.05.011.
4
Cost effectiveness of treatments for wet age-related macular degeneration.湿性年龄相关性黄斑变性治疗的成本效益。
Pharmacoeconomics. 2011 Feb;29(2):107-31. doi: 10.2165/11585520-000000000-00000.
5
Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?贝伐单抗用于治疗年龄相关性黄斑变性的超说明书用药：证据是什么？
Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002.
6
Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization.玻璃体内注射雷珠单抗（Lucentis）治疗近视性脉络膜新生血管。
Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):311-8. doi: 10.1007/s00417-008-0995-0. Epub 2008 Nov 29.

本文引用的文献

1
Retinal pigment epithelial tear after intravitreal ranibizumab.玻璃体内注射雷珠单抗后发生视网膜色素上皮撕裂
Am J Ophthalmol. 2007 Mar;143(3):505-7. doi: 10.1016/j.ajo.2006.11.047. Epub 2006 Dec 28.
2
Ranibizumab for neovascular age-related macular degeneration.雷珠单抗用于治疗新生血管性年龄相关性黄斑变性。
N Engl J Med. 2007 Feb 15;356(7):748-9; author reply 749-50.
3
Retinal pigment epithelial tear after intravitreal bevacizumab injection.玻璃体内注射贝伐单抗后视网膜色素上皮撕裂
Am J Ophthalmol. 2006 Dec;142(6):1070-2. doi: 10.1016/j.ajo.2006.07.037. Epub 2006 Sep 12.
4
Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients.两名患者玻璃体内游离贝伐单抗和游离血管内皮生长因子的水平
Retina. 2006 Oct;26(8):871-6. doi: 10.1097/01.iae.0000233327.68433.02.
5
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.雷珠单抗（一种抗血管内皮生长因子抗原结合片段）作为治疗新生血管性年龄相关性黄斑变性的药物的研发。
Retina. 2006 Oct;26(8):859-70. doi: 10.1097/01.iae.0000242842.14624.e7.
6
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.雷珠单抗与维替泊芬治疗新生血管性年龄相关性黄斑变性的比较。
N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655.
7
Ranibizumab for neovascular age-related macular degeneration.雷珠单抗用于治疗新生血管性年龄相关性黄斑变性。
N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481.
8
The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration.视力的代价——雷珠单抗、贝伐单抗与黄斑变性的治疗
N Engl J Med. 2006 Oct 5;355(14):1409-12. doi: 10.1056/NEJMp068185.
9
Age-related macular degeneration and risk for stroke.年龄相关性黄斑变性与中风风险
Ann Intern Med. 2006 Jul 18;145(2):98-106. doi: 10.7326/0003-4819-145-2-200607180-00007.
10
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗新生血管性年龄相关性黄斑变性的短期安全性和疗效
Retina. 2006 May-Jun;26(5):495-511. doi: 10.1097/01.iae.0000225766.75009.3a.